Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Aditya Birla Group proposes $1.26 billion expansion of Odisha alumina refinery
Aditya Birla Group plans a significant expansion for its Odisha alumina refinery. The company will invest an additional $1.26 billion to triple its current capacity. This substantial investment will bring the total proposed expenditure to about $2.1 billion. The expansion project will be managed by the group entity Hindalco Industries. This development aims to significantly boost alumina production in the region.
Life insurance new business premiums rise 16.6% in Q1 on private insurers' growth: Report
India's life insurance sector began FY27 with robust new business premiums, growing 16.6 percent. Private insurers significantly outpaced the market, increasing their share to nearly forty percent. This growth stemmed from steady retail product demand and a recovery in group business. Monthly premiums also saw a thirteen percent rise in June, reversing last year's contraction.
Auto sector to grow at 22-24% in Q1 FY27, among top drivers of corporate growth: Crisil
India's automobile sector is expected to report robust revenue growth of 22-24 per cent year-on-year in the first quarter of FY27, emerging as one of the biggest contributors to overall corporate revenue growth during the quarter, according to a Crisil report.
India Inc's revenue growth to hit 2-year high of 11-11.5% in Q1 despite Iran war: Crisil
India Inc's revenue is estimated to have grown 11-11.5% year-on-year in Q1FY27, marking the fastest pace in eight quarters, according to Crisil Intelligence. While pricing power helped companies offset higher input costs amid the West Asia conflict, margins remained under pressure due to rising fuel, freight and raw material expenses.
Banks and insurance are the bright spots, says Quantum AMC's Christy Mathai
Christy Mathai, Fund Manager at Quantum AMC, says most companies' input cost pressures will show up in quarter two rather than quarter one, as firms are still using cheaper stockpiled materials to protect margins. He expects a broader earnings recovery from the second half of the year, provided tensions in West Asia don't escalate further. Mathai is upbeat on private banks and life insurance, cautiously positive on select pharma names with US exposure, but is steering clear of chemical and defence stocks over stretched valuations. Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.
Stock Market Today Live, July 9: Sensex up 450 pts, trades at 76,956.50; Nifty up 155 pts; Sun Pharma, SBI Life, Bajaj Finserv top gainers - BusinessLine
Stock Market Today Live, July 9: Sensex up 450 pts, trades at 76,956.50; Nifty up 155 pts; Sun Pharma, SBI Life, Bajaj Finserv top gainersBusinessLine
Private life insurers outpace LIC in new business premium growth
Life insurers saw a 16.6% rise in new business premium during the April-June quarter. Private sector firms expanded faster than LIC, driven by regular premium products. Regular premium collections grew nearly twenty percent year-on-year, while single premium business increased. SBI Life Insurance emerged as the fastest-growing player among listed companies. Private insurers continue gaining market share while LIC retains its dominant position.
Private life insurers outpace LIC in new business premium growth
Life insurers saw a 16.6% rise in new business premium during the April-June quarter. Private sector firms expanded faster than LIC, driven by regular premium products. Regular premium collections grew nearly twenty percent year-on-year, while single premium business increased. SBI Life Insurance emerged as the fastest-growing player among listed companies. Private insurers continue gaining market share while LIC retains its dominant position.
Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why
Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.
Sun Pharmaceutical Industries Ltd spurts 0.07%, up for five straight sessions
Sun Pharmaceutical Industries Ltd is quoting at Rs 1914.2, up 0.07% on the day as on 12:44 IST on the NSE. The stock is up 14.45% in last one year as compared to a 4.11% fall in NIFTY and a 16.43% fall in the Nifty Pharma.
Gold overtakes vehicle loans as top securitised asset class in Q1FY'27: CRISIL
Securitisation, a process through which lenders pool loans and sell them to investors to raise funds and free up capital for fresh lending, saw issuances surge 22 per cent year-on-year to around Rs 60,000 crore in the April-June quarter, a CRISIL Ratings report said.
Poly Medicure among 4 stocks that closed below VWAP
Four Nifty500 stocks, Poly Medicure, Aditya Birla Real Estate, Siemens Energy India, and Onesource Specialty Pharma, closed over 2% below their VWAP on July 3, indicating potential bearish momentum and heightened selling pressure, according to technical scan data.